alexa Multidrug-resistant Tuberculosis | OMICS International | Mycobacterial Diseases

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Advancement on Fungal Infections 2020

New York, USA

Multidrug-resistant Tuberculosis

Multidrug-resistant tuberculosis (MDR-TB), defined as TB that is resistant to at least isoniazid (INH) and rifampicin (RIF). Treatment of MDR isolates requires the use of more costly and more toxic second-line drugs. Inappropriate treatment can result in the development of resistance to additional antibiotics and increase mortality. The detection of rifampicin resistance serves as surrogate marker for detecting MDR-TB.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on November, 2020